UBS Group »

Adial Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Adial Pharmaceuticals (ADIL) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Adial Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Adial Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adial Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $970 542 1.79

More positions owned by UBS Group

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl C (GOOG)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Ubs Group SHS (UBS)

View all positions for UBS Group

Top funds holding Adial Pharmaceuticals

Geode Capital Management
Vanguard Fiduciary Trust
Manchester Capital Management
BlackRock
UBS Group
Vanguard Capital Management
Morgan Stanley
SBI Securities
Caitong International Asset Management
Wells Fargo & Company
Northwestern Mutual Wealth Management Company
Harbour Investments
Abound Wealth Management

View all funds holding Adial Pharmaceuticals